Annual Drug Patent Expirations for ARMONAIR+RESPICLICK
Armonair Respiclick is a drug marketed by Teva Pharm and is included in a single NDA. It’s obtainable from one provider. There are 13 patents defending this drug.
Drug patent litigation for ARMONAIR RESPICLICK.
The generic ingredient in ARMONAIR RESPICLICK is fluticasone propionate. One provider is listed for this compound. Further particulars can be found on the fluticasone propionate profile web page.
For extra data on how DrugPatentWatch will help together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Initially printed at New patent for Teva Pharm drug ARMONAIR RESPICLICK